Dr Zhen Xu
Honorary (Fellow)
Department of Medical Biology (WEHI)
9 Scholarly works
0 Projects
HIGHLIGHTS
2024
Journal article
ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia
DOI: 10.1126/sciadv.adj88032021
Journal article
CHK2 inhibition provides a strategy to suppress hematologic toxicity from PARP inhibitors
DOI: 10.1158/1541-7786.MCR-20-07912021
Journal article
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias
DOI: 10.1182/blood.20200101672019
Journal article
Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma
DOI: 10.1111/bjh.160692019
Journal article
Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice
DOI: 10.1038/s41418-018-0209-12019
Journal article
Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia
DOI: 10.1158/2159-8290.CD-18-11192018
Conference Proceedings
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia
DOI: 10.1182/blood-2018-120761
RECENT SCHOLARLY WORKS
2017
Journal article
Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors
DOI: 10.1021/acsmedchemlett.7b003892016
Journal article
Plasmacytoid dendritic cells are short-lived: Reappraising the influence of migration, genetic factors and activation on estimation of lifespan
DOI: 10.1038/srep25060